Validation of a Novel Severe Acute Respiratory Syndrome Scoring System

Chan Ping Su, Wen Chu Chiang, Matthew Huei Ming Ma, Shey Ying Chen, Chiung Yuan Hsu, Patrick Chow In Ko, Kuang Chau Tsai, Chieh Min Fan, Fuh Yuan Shih, Shyr Chyr Chen, Yee Chun Chen, Shan Chwen Chang, Wen Jone Chen

研究成果: 雜誌貢獻文章同行評審

20 引文 斯高帕斯(Scopus)


Study objective: In a pilot study conducted during March 14 to April 2, 2003, 2 severe acute respiratory syndrome (SARS) screening scores were developed for predicting SARS among febrile patients presenting to the emergency department (ED). The objective of this study is to validate these scoring systems with a different set of patients. Methods: All adult patients with documented fever, measured at home or at the hospital, and presenting to the ED of National Taiwan University Hospital, a 2,400-bed tertiary care teaching hospital in northern Taiwan, were prospectively enrolled. Two previously developed SARS screening scores were applied to all patients. The final diagnosis of SARS was made by the Expert Committee of the Center for Disease Control Taiwan, Republic of China, according to the criteria of Centers for Disease Control and Prevention, Atlanta, GA. Results: A total of 239 adult patients, including 117 men and 122 women, were enrolled. Eighty-two patients were finally diagnosed with SARS. Compared with the SARS patients in the derivation cohort, those in the validation cohort were older (44.5±15.9 versus 33.9±15.9 years), more likely to acquire the disease locally (76.8% versus 37.5%), and more likely to have cough before or during fever. For the non-SARS patients, cases in the validation cohort presented with less cough and coryza but more diarrhea. For the 4-item symptom score, the sensitivity reached 96.3% (95% confidence interval [CI] 89.7% to 98.7%) and the specificity 51.6% (95% CI 43.8% to 59.3%). For the 6-item clinical score, the sensitivity reached 92.6% (95% CI 84.8% to 96.6%) and the specificity 71.2% (95% CI 63.6% to 77.7%). When the clinical score was applied to patients with a positive symptom score, the combined sensitivity reached 90.2% (95% CI 82.0% to 95.0%), and the combined specificity reached 80.1% (95% CI 73.2% to 85.6%). Conclusion: This prospective study validated the scoring system previously developed by using a different cohort. The scoring systems could be applied to settings where mass screening of SARS is needed during future outbreaks.

頁(從 - 到)34-42
期刊Annals of Emergency Medicine
出版狀態已發佈 - 1月 1 2004

ASJC Scopus subject areas

  • 急診醫學


深入研究「Validation of a Novel Severe Acute Respiratory Syndrome Scoring System」主題。共同形成了獨特的指紋。